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CASE REPORT
Successful amnioinfusion for severe 
fetal growth restriction with umbilical cord 
complications: two case reports
Daisuke Katsura1,2* , Yuichiro Takahashi2, Shigenori Iwagaki2, Rika Chiaki2, Kazuhiko Asai2, Masako Koike2, 
Shunichiro Tsuji1, Fuminori Kimura1 and Takashi Murakami1 
Abstract 
Background: There is no established treatment for fetal growth restriction during pregnancy. We report two cases 
that represent an example of an amnioinfusion-based management strategy for severe fetal growth restriction with 
umbilical cord complications.
Case presentation: We encountered two cases of fetal growth restriction with abnormal fetal Doppler velocity. In 
one case, fetal ultrasound revealed a hypercoiled umbilical cord with a single umbilical artery and oligohydramnios, 
while fetal Doppler revealed a reversed end-diastolic flow in the umbilical artery and reversed a-waves of the ductus 
venosus. Umbilical cord compression was confirmed at 22 weeks and 2 days of gestation, and nine amnioinfusions 
were performed to relieve the umbilical cord compression. A cesarean section was performed at 31 weeks and 2 days 
of gestation because of severe preeclampsia. The Asian infant is now a normally developed 6-month-old. In another 
Asian case, fetal ultrasound revealed a hypercoiled cord, while fetal Doppler revealed a reversed end-diastolic flow 
in the umbilical artery and intermittent reversed a-waves of the ductus venosus. Umbilical cord compression was 
confirmed at 24 weeks and 5 days of gestation, and seven amnioinfusions were performed. A cesarean section was 
performed at 31 weeks and 1 day of gestation because of nonreassuring fetal status. At the age of 1 month, the Asian 
infant was stable on respiratory circulation. In both cases, fetal Doppler findings improved significantly following 
amnioinfusions.
Conclusions: Amnioinfusion is a symptomatic treatment for umbilical cord compression. However, to determine the 
therapeutic effect of amnioinfusion, complete resolution of the umbilical cord compression should be ascertained by 
ultrasonography.
Keywords: Amnioinfusion, Fetal growth restriction, Oligohydramnios, Umbilical cord compression, Umbilical cord 
factors
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Background
Fetal growth restriction (FGR) is associated with neona-
tal morbidity and mortality, and requires intensive man-
agement [1]. FGR with oligohydramnios and abnormal 
fetal Doppler velocity are associated with severe placen-
tal insufficiency and perinatal mortality [2–4]. However, 
there is no established treatment for FGR during preg-
nancy. Therefore, delivery is considered depending on 
the gestational age and the estimated fetal weight (EFW).
Amnioinfusion (AI) is effective for treating variable 
decelerations in the fetal heart rate caused by umbilical 
cord compression with oligohydramnios [5, 6]. AI has 
also been reported to improve abnormal fetal Doppler 
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velocity in cases of FGR with oligohydramnios [4, 7, 8] 
and in those with umbilical cord compression without 
oligohydramnios [9]. However, the guidelines for man-
aging FGR and umbilical cord compression using AI are 
unclear. Herein, we report two cases of patients with 
extremely severe FGR with umbilical cord complications 
and abnormal fetal Doppler velocity, in whom AI was 
useful for prolonging gestation. These cases may pre-
sent an example of an AI-based management strategy for 
severe FGR with umbilical cord complications.
Case presentation
Case 1
A 33-year-old Asian woman (gravida 1, para 0) was 
referred and admitted to our hospital for the manage-
ment of FGR and oligohydramnios at 22  weeks and 
2 days of gestation. She had become pregnant via in vitro 
fertilization and had been followed up routinely by her 
obstetrician. She did not complain of water discharge. 
Fetal ultrasound screening revealed that the EFW, maxi-
mum vertical pocket, and coiling index were 204 g [−3.7 
standard deviation (SD)], 1.8 cm, and 0.76, respectively. 
FGR, oligohydramnios,  hypercoiled umbilical cord, and 
a single umbilical artery were detected. Fetal structural 
anomalies were not detected. On fetal Doppler, reversed 
end-diastolic flow in the umbilical artery (UA), reversed 
a-waves of the ductus venosus (DV), and pulsatile umbili-
cal venous flow were detected. Cardiotocography (CTG) 
revealed that the fetal heart rate at baseline was 150 beats 
per minute with no variability, and recurrent decelera-
tions were noted. Fetal death was imminent as there was 
umbilical cord compression caused by oligohydramnios 
and umbilical cord factors. Therefore, AI was performed 
for relieving cord compression. Under ultrasono-
graphic guidance, a 21-gauge percutaneous transhepatic 
cholangiography needle was introduced into the amni-
otic cavity, and 250  mL of warm saline was infused to 
achieve a normal amniotic fluid volume, as defined by an 
amniotic fluid index (AFI) of 12 cm.
Two days later, that is, at 22 weeks and 4 days of gesta-
tion, we observed an intermittent reversed end-diastolic 
flow in the UA and a-waves of the DV on fetal Doppler. 
Therefore, we believed that AI was effective, and per-
formed another AI as we observed that the umbilical 
cord was compressed between the placenta and the fetus 
(Fig.  1A), although oligohydramnios was not detected 
(AFI: 11  cm). Two days later, that is, at 22  weeks and 
6  days of gestation, a decreased baseline variability of 
the fetal heart rate, with no decelerations, was observed. 
Fetal Doppler showed a UA pulsatility index (PI) of 1.50, 
middle cerebral artery PI of 0.88, and DV-PI of 1.01. 
While the brain-sparing effect (cerebroplacental Doppler 
ratio 0.58) and a high DV-PI were noted, both CTG and 
fetal Doppler findings had improved. Therefore, when 
umbilical cord compression was confirmed by the detec-
tion of a sandwiched umbilical cord during ultrasonog-
raphy and reproducible variable decelerations on CTG, 
we repeated AI. At 25 weeks and 1 day of gestation, the 
patient was diagnosed with severe hypertensive disorders 
of pregnancy and was administered a calcium blocker. At 
26 weeks and 2 days of gestation, the umbilical cord com-
pression was found to have resolved on ultrasonography 
(Fig.  1B), and CTG showed normal baseline variability 
with accelerations. In total, nine AIs were performed.
A maternal urine protein level of 2 g per day was con-
firmed; therefore, corticosteroids and magnesium sulfate 
were administered for fetal lung maturation and neuro-
protection, respectively. Magnesium sulfate was admin-
istered until delivery. A cesarean section was performed 
at 31  weeks and 2  days of gestation because of severe 
Fig. 1. Fetal ultrasonography findings in case 1. A  The “sandwich sign,” that is, the umbilical cord sandwiched between the placenta and the fetus, 
is observed (white arrow). B The umbilical cord compression has resolved (white arrow)
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preeclampsia. A female infant, weighing 870 g, was born 
with Apgar scores of 8 at 1  minute and 8 at 5  minutes. 
Her umbilical arterial blood pH was 7.345, and she was 
admitted to the neonatal intensive care unit (NICU) 
because of the extremely low birth weight. In the NICU, 
she remained stable with directional positive airway pres-
sure, and was not diagnosed with the respiratory distress 
syndrome. She did not develop intraventricular hemor-
rhage, retinopathy of prematurity, chronic lung disease, 
or necrotizing enterocolitis. She was discharged home 
at 41  weeks and 6  days of adjusted gestational age, and 
weighed 2300 g at the time of discharge. She is being fol-
lowed up as an outpatient, and is presently a normally 
developed 6-month-old infant.
Case 2
A 33-year-old Asian woman (gravida 3, para 1) was 
admitted to our hospital for the management of FGR 
with an abnormal fetal Doppler velocity at 24 weeks and 
5  days of gestation. Owing to antithrombin deficiency, 
she was being administered heparin (10,000 units per 
day subcutaneously) and was infused with Neurt (3000 
units, three times per week). Fetal ultrasound screen-
ing revealed that the EFW, AFI, and coiling index were 
376 g (−3.2 SD), 12 cm, and 0.75, respectively. FGR and a 
hypercoiled umbilical cord were detected. Fetal structural 
anomalies were not detected. On fetal Doppler, reversed 
end-diastolic flow in the UA, intermittent reversed 
a-waves of the DV, and pulsatile umbilical venous flow 
were detected. Corticosteroids and magnesium sulfate 
were administered for fetal lung maturation and neuro-
protection, respectively. Magnesium sulfate was adminis-
tered for 2 days. We observed that the umbilical cord was 
compressed between the placenta and the fetus, although 
oligohydramnios was not detected (Fig.  2A). Therefore, 
we performed AI for relieving umbilical cord compres-
sion, because it was considered to be an underlying cause 
of the deterioration of fetal condition. After the umbili-
cal cord compression was found to be resolved by AI 
on ultrasonography (Fig.  2B), we observed an UA-PI of 
1.84, MCA-PI of 1.19, and DV-PI of 1.08. Though a brain-
sparing effect (cerebroplacental Doppler ratio 0.64) and a 
high DV-PI were noted, the fetal Doppler findings were 
improved. This suggested that AI was effective. There-
fore, we repeated AI when umbilical cord compression 
was confirmed by the detection of a sandwiched umbili-
cal cord during ultrasonography and reproducible vari-
able decelerations during CTG. In total, seven AIs were 
performed.
At 31  weeks and 1  day of gestation, we observed 
reversed end-diastolic flow in the UA and intermittent 
reversed waves of the DV on fetal Doppler, as well as fre-
quent variable decelerations on CTG; however, umbili-
cal cord compression was not confirmed. Therefore, a 
cesarean section was performed because of nonreassur-
ing fetal status. A male infant, weighing 760 g, was born 
with Apgar scores of 4 at 1  minute and 9 at 5  minutes. 
His umbilical arterial blood pH was 7.308, and he was 
admitted to the NICU because of the extremely low birth 
weight. In the NICU, he was managed with directional 
positive airway pressure and was extubated at 12 days of 
age. At the age of 1 month, he remained stable on respira-
tory circulation.
Discussion
Herein, we have reported the cases of two patients with 
extremely severe FGR with umbilical cord complications 
and abnormal fetal Doppler velocity, in whom AI was 
useful for prolonging gestation. Although fetal death was 
imminent, we could not deliver the patients because of 
Fig. 2. Fetal ultrasonography findings in case 2. A The “sandwich sign,” that is, the umbilical cord sandwiched between the placenta and the fetus, is 
observed (white arrow). B The umbilical cord compression has resolved (white arrow)
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the gestational age and the EFW, as the infants would not 
have survived. We believe that the umbilical cord blood-
flow disturbance, which was caused by umbilical cord 
compression secondary to entire or local oligohydram-
nios arising from umbilical cord complications (such as 
a hypercoiled cord and a single umbilical artery), contrib-
uted to the severe condition of the patients. Takahashi 
et  al. and Iwagaki et  al. reported an improvement in 
abnormal UA and DV Doppler findings after administra-
tion of AI in cases with FGR with oligohydramnios and 
umbilical cord complications [4, 8]. Repetitive umbilical 
cord compression induces fetal asphyxia [4, 10], and AI 
relieves umbilical cord compression, decreases the vas-
cular resistance of UA, increases umbilical venous blood 
flow, and improves oxygenation and the intrauterine 
environment [9]. However, the efficacy of AI has not yet 
been established. Therefore, we informed these patients 
about AI and the associated complications before obtain-
ing their consent. Our findings were similar to those of 
a previous study [9], wherein the sandwich sign, indica-
tive of the umbilical cord being sandwiched between the 
placenta and the fetus resulting in cord compression, was 
detected on ultrasonography, although oligohydramnios 
had resolved. In case 1, the initial AI improved the fetus’s 
well-being slightly, but the second AI in case 1 and the 
initial AI in case 2, which relieved the umbilical compres-
sion, markedly improved the intrauterine conditions. We 
believe that the umbilical cord blood-flow disturbance 
was one of the causes of fetal complications, and com-
plete resolution of the umbilical cord compression was 
necessary. Hence, repeated AIs led to improved CTG and 
fetal Doppler findings, which allowed for longer preg-
nancies, resulting in the survival of the infants without 
sequelae.
AI is not a suitable treatment for the following factors: 
(1) umbilical factors such as a hypercoiled umbilical cord 
and an abnormal umbilical cord insertion, (2) placental 
factors such as hypertensive disorders of pregnancy and 
massive subchorionic hematomas, and (3) fetal factors 
such as chromosomal abnormalities, congenital anoma-
lies, and infections. Instead, it is a treatment for umbili-
cal cord blood-flow disturbances caused by umbilical 
cord compression secondary to entire or local oligohy-
dramnios that is caused by these factors [4, 9]. Case 1 was 
associated with umbilical and placental factors, as hyper-
tensive disorders of pregnancy developed and led to the 
delivery of the infant. Case 2 was associated with umbili-
cal cord blood-flow disturbance as an umbilical factor 
secondary to a hypercoiled umbilical cord, which deteri-
orated and led to the delivery of the infant. Therefore, AI 
is a symptomatic treatment for umbilical cord compres-
sion; it is not an accurate treatment for FGR.
Adverse events related to AI have been reported, 
including premature rupture of membranes, preterm 
labor, placental abruption, chorioamnionitis, fetal 
trauma, and uterine perforation [11]; therefore, AI should 
only be performed in carefully selected patients by well-
trained experts. In cases with umbilical cord compres-
sion secondary to local oligohydramnios, changes in the 
maternal position or fetal movement might relieve the 
compression. Therefore, we considered reproducible var-
iable decelerations on CTG as the indication for AI. The 
efficacy of AI has not yet been established, and though 
AI may cause some complications, there are no detailed 
studies on the complications of AI. Therefore, further 
studies are needed to clarify the efficacy of AI.
In addition, we generally undertake CTG examinations 
from 26  weeks of gestation, because the developmental 
state of the fetal autonomic nervous system must be con-
sidered for the interpretation of CTG findings [12], and 
there is limited knowledge on the CTG findings regard-
ing FGR in fetuses at less than 26 weeks of gestation [13]. 
In our cases, although the gestational age was less than 
26  weeks, we performed CTG to confirm the absence 
of umbilical cord compression, because umbilical cord 
compression causes variable deceleration on CTG [9, 14].
Conclusion
Although amnioinfusion is a symptomatic treatment for 
umbilical cord compression, it was a life-saving thera-
peutic strategy for the patients described in this report. 
However, to determine the therapeutic effect of amnioin-
fusion, complete resolution of the sandwich sign, which 
indicates umbilical cord compression in cases of FGR 
with umbilical cord complications, must be ascertained 
by ultrasonography.
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